Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC)

1.56
Delayed Data
As of 3:59pm ET
 -0.0234 / -1.48%
Today’s Change
1.47
Today|||52-Week Range
10.90
-10.54%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues1.1M1.7M1.9M843.0K
 
 
 
 
 
Depreciation And Amortization70.0K174.0K210.0K133.0K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses19.0M24.0M17.9M14.9M
 
 
 
 
 
Research And Development11.3M18.1M12.2M9.3M
 
 
 
 
 
Total Operating Expenses19.1M24.2M18.1M15.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-18.0M-22.4M-16.2M-14.2M
 
 
 
 
 
Extraordinary Credit570.0K--0.000.00
 
 
Extraordinary Charge0.00-322.0K-51.0K0.00
 
 
 
Other Expenses5.5M104.0K-274.0K339.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-11.9M-22.6M-16.5M-13.8M
 
 
 
 
 
Income Taxes-1.7M-3.2M-2.1M-2.0M
 
 
 
 
 
Preferred Dividend-9.3M-200.0K-201.0K-200.0K
 
 
 
 
 
Discontinued Operations57.0K19.0K0.000.00
 
 
 
Net Income-10.2M-19.4M-14.3M-11.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS1.3M1.8M2.7M3.4M
 
 
 
 
 
Shares To Calculate EPS Diluted1.3M1.8M2.7M3.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$15.36-$10.68-$5.40-$3.50
 
 
 
 
 
EPS Diluted-$15.36-$10.68-$5.40-$3.50